What Is AOD-9604?
AOD-9604 is a fragment of human growth hormone — specifically the piece responsible for fat mobilization — without growth hormone's effects on blood sugar or tissue growth.
AOD-9604 takes a different approach to fat loss than the GLP-1 drugs. Instead of suppressing your appetite, it targets fat mobilization directly — it tells your body to break down stored fat and use it for energy.
It's a fragment of human growth hormone. Specifically, it's the piece of growth hormone responsible for fat metabolism, isolated from the rest of the molecule. You get the fat-burning effect without growth hormone's other actions on blood sugar, muscle growth, or organ enlargement.
What AOD-9604 Actually Is
Human growth hormone is a large protein with many effects — muscle growth, fat metabolism, blood sugar regulation, bone density, organ growth. Researchers identified that a specific section of the molecule — amino acids 177 through 191 — was primarily responsible for the fat metabolism effects.
They isolated that 16-amino-acid fragment and modified it slightly to improve stability. The result is AOD-9604 (AOD stands for Advanced Obesity Drug).
The key feature: AOD-9604 mimics growth hormone's ability to mobilize fat without the other effects of full growth hormone. It doesn't raise blood sugar. It doesn't promote organ or bone growth. It doesn't affect IGF-1 levels significantly. It's a targeted tool for one specific job.
How It Works
AOD-9604's mechanism involves:
Fat Mobilization (Lipolysis)
It stimulates the breakdown of stored fat (triglycerides) into fatty acids that can be burned for energy. This process — lipolysis — is one of growth hormone's primary metabolic functions. AOD-9604 activates this pathway without activating growth hormone's other pathways.
Inhibiting Lipogenesis
Research suggests AOD-9604 may also inhibit lipogenesis — the process of converting excess calories into stored fat. So it works both ways: more fat breakdown, less new fat creation.
Beta-3 Adrenergic Receptor Activity
Some research indicates AOD-9604 may interact with beta-3 adrenergic receptors, which are involved in fat cell metabolism and thermogenesis (heat production from fat burning).
What the Research Shows
Animal Studies (Rat Data)
AOD-9604 showed strong results in obese rat models:
- Significant reduction in body fat
- No effect on blood sugar levels
- No effect on IGF-1 levels
- Weight loss was specific to fat tissue, not muscle or organ mass
These results were encouraging because they demonstrated the selective fat-targeting mechanism worked as intended.
Human Clinical Trials (Mixed Results)
AOD-9604 went through human clinical trials for obesity. Here's where the story gets complicated:
- Early trials showed some fat loss benefits
- Later, larger trials showed modest results that didn't meet the endpoints needed for FDA approval as a standalone obesity drug
- The peptide was not approved as a pharmaceutical drug for weight loss
This doesn't mean it doesn't work — it means it didn't work well enough in clinical trials to compete with the standards for FDA obesity drug approval. The effect was real but modest, especially for people with significant obesity (50-100+ pounds to lose).
Regulatory Status
AOD-9604 was granted GRAS (Generally Recognized as Safe) status by the FDA for use as a food substance in 2015. This means the FDA considers it safe for consumption, though not approved as a drug for any specific medical condition.
In Australia, AOD-9604 has been more widely studied and was part of clinical development programs for obesity.
Where AOD-9604 Actually Shines
The community consensus — supported by the clinical data pattern — is that AOD-9604 is not an aggressive fat loss tool for major obesity. It's more of a finisher.
Who It Works Best For
- People who are relatively lean and trying to lose the last 10-15 pounds
- People who've already lost significant weight and have stubborn remaining fat
- Athletes or bodybuilders in a cutting phase looking for an edge
- People who want mild fat mobilization support without the appetite changes or GI side effects of GLP-1 drugs
Who It's Not Great For
- People who need to lose 50-100+ pounds (GLP-1 drugs are far more effective)
- Anyone expecting dramatic, rapid fat loss
- People looking for appetite suppression (AOD-9604 doesn't significantly affect appetite)
How People Use AOD-9604
Subcutaneous Injection
The most common route. Typical community protocols: 250-300 mcg per day, injected subcutaneously, usually in the morning on an empty stomach (the theory being that fasted-state injection may enhance fat mobilization).
Oral Supplements
AOD-9604 is available in some oral supplement formulations, leveraging its GRAS status. Oral bioavailability is lower than injection.
Duration
Typical cycles: 4-12 weeks. Some people use it continuously at low doses.
Stacking
Some people combine AOD-9604 with other peptides:
- With CJC-1295/Ipamorelin for growth hormone synergy
- With semaglutide or tirzepatide for added fat mobilization on top of appetite suppression
Safety
AOD-9604 has one of the cleaner safety profiles in the peptide space:
- FDA GRAS status (safe for consumption)
- Human clinical trial data with mild side effect profile
- No significant effect on blood sugar (unlike full growth hormone)
- No significant effect on IGF-1 levels
- No reported organ growth or other growth hormone-related concerns
- Common side effects: mild injection site reactions, occasional headache
The safety profile is a genuine strength of this peptide. It's one of the few that has both human trial data and an FDA safety determination.
The Bottom Line
AOD-9604 is a growth hormone fragment that targets fat mobilization without growth hormone's other effects. The animal data is strong. The human data is real but modest — it didn't meet the bar for FDA approval as an obesity drug, but it showed genuine fat loss effects.
It's not the peptide for major weight loss. For that, GLP-1 drugs are in a different league. But for people who are already relatively lean and dealing with stubborn fat, AOD-9604 offers a targeted, well-tolerated option that works through a completely different mechanism than appetite suppression. It's a scalpel, not a sledgehammer.